Status:

ACTIVE_NOT_RECRUITING

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

The University of Texas at Arlington

Conditions:

Heart Failure, Diastolic

Eligibility:

All Genders

60-90 years

Phase:

NA

Brief Summary

The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific ...

Detailed Description

This will be a randomized, non-blinded prospective intervention testing the effects of two types of exercise training, whole body and isolated single leg, on HFpEF patients with either central or peri...

Eligibility Criteria

Inclusion

  • signs and symptoms of heart failure
  • an ejection fraction \> 0.50
  • objective evidence of diastolic dysfunction

Exclusion

  • age \< 60 years
  • BMI \> 50 kg/m2
  • PDE5 inhibitor use
  • Severe valvular disease
  • Severe COPD
  • CKD 4 or higher
  • Contra-indication to MRI.

Key Trial Info

Start Date :

August 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2025

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT04068844

Start Date

August 1 2019

End Date

December 31 2025

Last Update

January 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Institute for Exercise and Environmental Medicine

Dallas, Texas, United States, 75231